Market expansion CSP is expanding its footprint with a recent San Diego ambulatory infusion suite, signaling a growth opportunity to engage hospitals, clinics, and health systems in California and beyond that require specialized infusion and IG therapy services.

Specialized care With an Immunoglobulin Center of Excellence and high-touch patient care model, CSP can be positioned to partner with health plans and medical groups seeking enhanced outcomes and cost management for complex IG and rare disease therapies.

Integrated partnerships CSP highlights unique partnerships with health plans, medical groups, and manufacturers, presenting a gateway for channel partnerships, co-marketing, and formulary collaboration to broaden access and referral networks.

Revenue potential Reported revenue range of 25 to 50 million and multi-state operations across 17 states indicate scalable service lines in specialty pharmacy and infusion, suggesting cross-sell opportunities to existing customers and expansion within affiliated accounts.

Clinical differentiation Robust clinical management and financial advocacy programs position CSP as a value-driving partner for payers and providers seeking cost containment and patient-focused outcomes in complex therapies, enabling value-based selling discussions.